Medically reviewed by Smita Patel, DO Migraine is a complex neurological disorder known for causing severe headaches. People ...

Migraine disrupts daily life with invisible neurological pain, causing physical, emotional, and cognitive struggles that go ...

Migraine is a recurrent and complex neurological disorder that can affect the quality of your life. Identifying triggers, ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Galcanezumab provided greater reductions in migraine frequency, resulting in a shift from chronic to episodic migraine over a 12-month period compared with placebo.

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

The drug – a new dry powder intranasal formulation of the old migraine therapy dihydroergotamine mesylate (DHE) – showed a trend towards improvements in pain and other symptoms in the phase 3 ...

According to Olivia Begasse de Dhaem, MD, a neurologist and headache medicine specialist at Hartford Healthcare in Connecticut: “Cognitive dysfunction is common during all phases of migraine.

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...